Min wrote:
"Prof Wessely is also allegedly a member of the supervisory board of a company named PRISMA."
Min,
It is known that Prof Wessely had been a member of PRISMA Health supervisory board, but it is understood that he has not been for some years now.
An enquiry to PRISMA Health asking then to confirm the year in which Prof Wessely ceased involvement with PRISMA Health would be useful. Did not Holmsey also post that Prof Wessely had confirmed to him by email that he was no longer involved with PRISMA Health?
These are the currently available Way Back Machine archived pages for PRISMA Health:
http://web.archive.org/web/*/http://prismahealth.com
Search Results for Jan 01, 1996 - Aug 20, 2009
Those requiring documentary evidence might like to keep this link on file, also from the Way Back Machine archived webpages.
The material below was supplied to me by someone who held it on file. These pages may not necessarily still be available on the Way Back Machine, but they come from a trusted source.
The URL paths suggests that they both date from 2001.
http://web.archive.org/web/20010302091247/www.prismahealth.com/ENGLISH/COMPANY/OFFICERS.HTM
Supervisory Board
RA Georg F. Thoma (President), German, is managing partner at Shearman &
Sterling, a leading international law firm. Mr. Thoma's broadly based
practice concentrates on capital market and M&A transactions. He has
been the leading lawyer in major deals such as the Daimler Benz -
Chrysler Corporation merger. Mr. Thoma is regarded as one of the top M&A
lawyers worldwide.
Prof. Dr. Michael Adams, German, is leading the institute for Law and
Economics at the Hamburg University. He is adviser to the German
Administration and Supervisory Board member of a number of well-known
German corporations.
Dr. Fons Dekkers, Dutch, international specialist on patient’s rights
and information. He is director of the Dutch Federation of Patients’ and
Consumer organisations and for Europe Vice-president of the European
Public Health Alliance. Published many articles and books over the last
20 years on rights of patient and citizens in healthcare.
Dr. Peter Jaensch, German, is CEO of GFKL Financial Services AG and
Supervisory Board member of several innovative and service companies.
Prof. Dr. Simon Wessely, British, is regarded as a world leading expert
in the field of medically unexplained illnesses. He has been publishing
extensively on chronic fatigue and is leading, among other things, the
Chronic Fatigue Unit at the King’s College in London.
http://web.archive.org/web/20010303020427/www.prismahealth.com/ENGLISH/JOBOFF~1/General.HTM
[...]
General Information
The Company
PRISMA Health is an independent team of experts specialising in the
assessment and treatment of long-term disabilities resulting from
complex chronic illnesses. We are helping in particular those clients
who have been diagnosed as having a ‘medically unexplained illness’ such
as Chronic Fatigue Syndrome, Chronic Pain and Fibromyalgia. Usually
these patients are unable to carry out full time employment or lead
normal lives. We provide a unique and highly effective resolution
program for this group of clients and work closely with insurance and
re-insurance companies throughout Europe.
Senior executives from the European financial and healthcare industry
founded PRISMA Health AG in 1999. The Company has its headoffice in
Essen, Germany, in the heart of one of Europe’s largest economic
regions, the ‘Ruhrgebiet’. Operating companies have been established in
the United Kingdom, Denmark, the Netherlands and Canada.
The Prisma Program
Research shows that 30-40% of people who claim long-term disability
benefits suffer from ‘medically unexplained illnesses’ Examples of the
conditions, as described by health professionals worldwide, are Chronic
Fatigue Syndrome, Fibromyalgia and Chronic Pain. These can be severely
disabling conditions for which no clear organic or orthopaedic cause can
be identified.
People who fall into this category of illness, i.e. have been ill for
many years and unable to work, will require a specific treatment program
designed to resolve their disability and hopefully help them lead a
normal life. To this end, PRISMA has developed a unique and
evidence-based treatment protocol that has been shown to resolve the
long-term disabilities of this group of clients. The program is
tailor-made for the individual, is intensive and involves a variety of
medical and psychological disciplines. It is delivered by highly skilled
staff and takes place in the client’s local environment – home and
workplace – over a five to seven month period.
